Delivery Order SPE2DB22D3004-SPE2DB25FRC64

Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a firm fixed price of $1,385.52 and a period of performance through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 16, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,385.52, is for the pharmaceutical product Orgovyx 120 mg tablets. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a ceiling value of $2,771.04 and a period of performance through June 5, 2025. It is a firm-fixed-price contract type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,989.67 contract is for the delivery of the prescription drug Orgovyx 120 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order contract is for the medication Orgovyx 120 mg tablet, with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of the prescription medication Orgovyx 120 mg tablets, with a ceiling value of $6,927.60 and a period of performance through May 27, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,989.67, is for the procurement of the pharmaceutical drug Orgovyx 120 mg Tablet. The contract has a period of performance through December 5, 2024 and is a firm fixed-price contract. This contract award is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Orgovyx 120 mg Tablet, with a ceiling value of $7,979.34 and a period of performance through May 24, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This firm fixed price delivery order worth $3,989.67 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for Orgovyx 120 mg tablets and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FRC64
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,156.56, is for the delivery of Orgovyx 120 mg tablets. The contract has a performance period through July 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order contract is likely part of the company's broader support for federal medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 9/16/25, 10:01 AM